BSE Live
Sep 05, 16:01Prev. Close
3325.75
Open Price
3318.50
Bid Price (Qty.)
3242.00 (5)
Offer Price (Qty.)
3257.85 (1)
NSE Live
Sep 05, 15:51Prev. Close
3319.40
Open Price
3309.00
Bid Price (Qty.)
3249.60 (7)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Dr Lal PathLabs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 83.35 | 83.34 | 83.33 | 83.07 | 82.68 | |
Total Share Capital | 83.35 | 83.34 | 83.33 | 83.07 | 82.68 | |
Reserves and Surplus | 900.12 | 847.49 | 693.19 | 503.37 | 395.84 | |
Total Reserves and Surplus | 900.12 | 847.49 | 693.19 | 503.37 | 395.84 | |
Total Shareholders Funds | 1,016.35 | 930.84 | 776.52 | 586.44 | 478.51 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 90.40 | 1.22 | 7.95 | 7.19 | 23.51 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 90.40 | 1.22 | 7.95 | 7.19 | 23.51 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 112.70 | 77.17 | 62.42 | 50.62 | 40.58 | |
Other Current Liabilities | 84.16 | 44.19 | 40.28 | 25.32 | 17.41 | |
Short Term Provisions | 14.40 | 13.10 | 8.42 | 6.64 | 30.96 | |
Total Current Liabilities | 211.26 | 134.46 | 111.12 | 82.58 | 88.96 | |
Total Capital And Liabilities | 1,318.00 | 1,066.51 | 895.59 | 676.20 | 591.72 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 277.10 | 151.31 | 151.65 | 103.28 | 104.33 | |
Intangible Assets | 19.54 | 21.64 | 20.88 | 17.71 | 25.45 | |
Capital Work-In-Progress | 10.30 | 2.87 | 9.36 | 15.33 | 4.09 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 307.94 | 175.82 | 181.90 | 138.19 | 133.88 | |
Non-Current Investments | 93.88 | 32.37 | 29.72 | 31.32 | 11.59 | |
Deferred Tax Assets [Net] | 22.20 | 21.08 | 16.41 | 13.19 | 11.44 | |
Long Term Loans And Advances | 0.03 | 0.01 | 0.05 | 0.05 | 15.54 | |
Other Non-Current Assets | 31.62 | 41.00 | 54.76 | 37.60 | 3.20 | |
Total Non-Current Assets | 455.66 | 270.28 | 282.83 | 220.34 | 175.64 | |
CURRENT ASSETS | ||||||
Current Investments | 158.89 | 181.67 | 143.85 | 102.96 | 62.59 | |
Inventories | 55.00 | 27.81 | 26.65 | 17.14 | 14.08 | |
Trade Receivables | 50.30 | 53.10 | 40.18 | 40.26 | 34.86 | |
Cash And Cash Equivalents | 549.20 | 478.11 | 306.78 | 234.72 | 226.43 | |
Short Term Loans And Advances | 0.90 | 0.94 | 0.25 | 0.16 | 71.51 | |
OtherCurrentAssets | 48.05 | 54.60 | 95.05 | 60.63 | 6.61 | |
Total Current Assets | 862.34 | 796.23 | 612.76 | 455.87 | 416.07 | |
Total Assets | 1,318.00 | 1,066.51 | 895.59 | 676.20 | 591.72 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 19.00 | 9.16 | 8.49 | 0.00 | 23.96 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 1.16 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 5.94 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 8.60 | 8.83 | 0.00 | 0.00 | 8.29 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | 0.00 | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | 2.54 | |
Other Earnings | 17.70 | 15.51 | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 50.32 | 50.32 | 50.32 | 50.32 | 50.32 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 93.88 | 32.37 | 29.72 | 31.32 | 11.59 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | 158.89 | 181.67 | 143.85 | 102.96 | 62.59 |
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
22.07.2025
23.06.2025
Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
25.04.2025
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
25.04.2025
Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak